1-1 of 1
Authors: C. Picard-Dahan
Journal Article
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 8, August 2011, Pages 1869–1877, https://doi.org/10.1093/jac/dkr208
Published: 01 June 2011
